71 research outputs found
Relation of maternal vitamin D status with gestational diabetes mellitus and perinatal outcome
Objective: To investigate the relationship between maternal vitamin D
status and glucose intolerance, and its impact on pregnant women and
their newborns. Methods: A cohort of pregnant women were divided into
three groups: women with gestational diabetes mellitus, ones with
normal results both after the 50 gr and 100 gr OGTT (CG-1) and ones
having a positive result after the 50 gr OGTT screening but negative
results for gestational diabetes mellitus (GDM) after the 100 gr OGTT
(CG-2) Results: The newborn length in CG-1 was greater than in GDM and
CG-2 (p= 0.002 and p= 0.02). Fasting blood glucose and insulin
resistance (IR) were negatively correlated with length of the newborns
(r=-0.3, p=0.03 and r=-0.3, p=0.01). The newborns of women with GDM had
lower APGAR-1 and 5 scores than those of CG-1 and CG-2 (APGAR-1 p=
0.001 and p= 0.004, APGAR-5 p=0.005 and p=0.007, respectively). APGAR
scores were correlated negatively with IR (APGAR-1 r=- 0.32, p=0.01,
APGAR-5 r=-0.3, p=0.03) and positively with 25OHD levels (APGAR-1
r=0.3, p=0.01, APGAR-5 r=0.3, p=0.02). Conclusion: Vitamin D
deficiency, gestational diabetes and insulin resistance are
interrelated. Severe vitamin D deficiency during pregnancy is
associated with poor pregnancy and neonatal outcome
Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition
Idiopathic pulmonary fibrosis (IPF) is the most common and most deadly form of interstitial lung disease. Osteopontin (OPN), a matricellular protein with proinflammatory and profibrotic properties, plays a major role in several fibrotic diseases, including IPF; OPN is highly upregulated in patients' lung samples. In this study, we knocked down OPN in a bleomycin (BLM)-induced pulmonary fibrosis (PF) mouse model using small interfering RNA (siRNA) to determine whether the use of OPN siRNA is an effective therapeutic strategy for IPF. We found that fibrosing areas were significantly smaller in specimens from OPN siRNA-treated mice. The number of alveolar macrophages, neutrophils, and lymphocytes in bronchoalveolar lavage fluid was also reduced in OPN siRNA-treated mice. Regarding the expression of epithelial-mesenchymal transition (EMT)-related proteins, the administration of OPN-siRNA to BLM-treated mice upregulated E-cadherin expression and downregulated vimentin expression. Moreover, in vitro, we incubated the human alveolar adenocarcinoma cell line A549 with transforming growth factor (TGF)-beta 1 and subsequently transfected the cells with OPN siRNA. We found a significant upregulation of Col1A1, fibronectin, and vimentin after TGF-beta 1 stimulation in A549 cells. In contrast, a downregulation of Col1A1, fibronectin, and vimentin mRNA levels was observed in TGF-beta 1-stimulated OPN knockdown A549 cells. Therefore, the downregulation of OPN effectively reduced pulmonary fibrotic and EMT changes both in vitro and in vivo. Altogether, our results indicate that OPN siRNA exerts a protective effect on BLM-induced PF in mice. Our results provide a basis for the development of novel targeted therapeutic strategies for IPF
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
We found that 19 (10.4%) of 183 unvaccinated children hospitalized for COVID-19 pneumonia had autoantibodies (auto-Abs) neutralizing type I IFNs (IFN-alpha 2 in 10 patients: IFN-alpha 2 only in three, IFN-alpha 2 plus IFN-omega in five, and IFN-alpha 2, IFN-omega plus IFN-beta in two; IFN-omega only in nine patients). Seven children (3.8%) had Abs neutralizing at least 10 ng/ml of one IFN, whereas the other 12 (6.6%) had Abs neutralizing only 100 pg/ml. The auto-Abs neutralized both unglycosylated and glycosylated IFNs. We also detected auto-Abs neutralizing 100 pg/ml IFN-alpha 2 in 4 of 2,267 uninfected children (0.2%) and auto-Abs neutralizing IFN-omega in 45 children (2%). The odds ratios (ORs) for life-threatening COVID-19 pneumonia were, therefore, higher for auto-Abs neutralizing IFN-alpha 2 only (OR [95% CI] = 67.6 [5.7-9,196.6]) than for auto-Abs neutralizing IFN-. only (OR [95% CI] = 2.6 [1.2-5.3]). ORs were also higher for auto-Abs neutralizing high concentrations (OR [95% CI] = 12.9 [4.6-35.9]) than for those neutralizing low concentrations (OR [95% CI] = 5.5 [3.1-9.6]) of IFN-omega and/or IFN-alpha 2
Discontinuation of somatostatin analogs while acromegaly is in long-term remission
We aimed to evaluate the disease activity of medically controlled patients with acromegaly after withdrawal of somatostatin receptor ligands (SRL)
Pituitary stone: a case report and review of the literature
A 39-year-old male without any significant complaints or symptoms presented with a calcified lesion located at the sellar region.Total removal of the lesion has been achieved via an endoscopic endonasal transsphenoidal approach. Histopathological examination of the lesion revealed a pituitary stone
Pituitary Stone: A Case Report and Review of the Literature
A 39-year-old male without any significant complaints or symptoms presented with a calcified lesion located at the sellar region.Total removal of the lesion has been achieved via an endoscopic endonasal transsphenoidal approach. Histopathological examination of the lesion revealed a pituitary stone
Increased incidence of pelvic organ prolapse in women with acromegaly
Objective: To evaluate gynecological problems of female patients with acromegaly and the relationship of these problems with the activity of the disease
Case report: POEMS syndrome in childhood
POEMS syndrome is a rare multisystem disorder, which is characterized by polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes. We report a 15-year-old girl with POEMS syndrome, who developed growth retardation, delayed puberty, gradually increasing abdominal distention, brown skin pigmentation, hypogonadism, hepatosplenomegaly, lympadenomegaly, monoclonal gammopathy, and anemia. The patient dramatically responded to pulse steroid therapy. To our knowledge, this patient is one of the youngest reported cases of POEMS syndrome
- …